Skip to main content
SpringerLink
Log in

The Present Status of Clinical Use of Levamisole

  • Chapter
Immunomodulation

Abstract

Levamisole (LMS) is the levorotatory isomer of Tetramisole, whose potent antihelminthic activity has been known since 1966.1 In 1971 Renoux and Renoux2 found that LMS could potentiate immunity in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. Thienpont, O.F.J. Vanparijs, A.H.M. Raeymaekers, J. Vandenberk, P.J.A. Demen, F.T.N. Allewijn, R.P.H. Marsboom, C.J.E. Niemegeers, K.H.R. Schellekens, and P.A.J. Janssen, Tetramisole (R 8299) a new potent broad spectrum antihelmintic. Nature (Lond.) 209: 1084 (1966).

    Article  CAS  Google Scholar 

  2. G. Renoux, and M. Renoux, Effet immunostimulant d’un imidothiazole dans l’immunisation des souris contre 1’infection par Brucella abortus. C.R. hebd.Seanc. Acad. Sci. Paris 272: 349 (1971).

    CAS  Google Scholar 

  3. J. Symoens, M. Rosenthal, M. De Brabander, and G. Goldstein, Immunoregulation with Levamisole. Springer Semin. Immunopathol. 2: 49 (1979).

    Article  CAS  Google Scholar 

  4. N. Moriya, T. Miyawaki, H. Seki, M. Kubo, T. Nagaoki, N. Okuda, and N. Taniguchi, Induction of suppressor activity on B-cell differentiation in human T-cell subset without Fc(IgG) receptor by levamisole administration. Scand. J. Immunol. 10: 535 (1979).

    Article  PubMed  CAS  Google Scholar 

  5. G. Luzi, R. Bonomo, A. Nastari, and F. Aiuti, Il levamisole in immunodeficienze primitive e nel corso di cheratite erpetica recidivante, in: “Sostanze immunomodulanti: il levamisole,” G. Visco, ed., L. Pozzi Publication, Roma (1981).

    Google Scholar 

  6. R.J. O’Reilly, A. Chibbaro, R. Wilmot, and C. Lozez, Correlation of clinical and virus-specific immune response following levamisole therapy of recurrent herpes progenitalis. Ann. N.Y. Acad. Sci. 284: 161 (1977).

    Article  PubMed  Google Scholar 

  7. A.N. Lubetkin, R.F. Remedi, M. Granerò, and O. Brarda, Levamisol en el tratamiento de las infecciones urinarias recurrentes. Boi. Med. Hosp. Infant. 36: 1109 (1979).

    CAS  Google Scholar 

  8. E. Barbaix, Effectiveness of levamisole in preventing complications of measles in high-risk infants and children. Janssen Clin. Res. Rep. N. 53.

    Google Scholar 

  9. D.G. Jose, and C.C.J. Minty, Levamisole in patients with recurrent herpes infection. Med. J. Australia 2: 390 (1980).

    PubMed  CAS  Google Scholar 

  10. T.L. Vischer, E. Veys, J. Symoens, M. Rosenthal, and E.C. Huskisson, Levamisole in rhematoid arthritis: A randomized double-blind study comparing two-dosage regimens of levamisole with placebo. Lancet 2: 1007 (1978).

    Google Scholar 

  11. T. Di Perri, A. Auteri, and F. Laghi-Pasini, Il levamisolo neltrattamento dell’artrite reumatoide, in: “Sostanze immuno-modulanti: il levamisolo,” G. Visco, ed., L. Pozzi Publ., Roma (1981).

    Google Scholar 

  12. W. Amery, Final results of a multicenter placebo-controlied levamisole study of resectable lung cancer. Cancer Treat. Rep. 62: 1677 (1978).

    PubMed  CAS  Google Scholar 

  13. H. Verhaegen, W. De Cock, J. De Cree, F. Verbruggen, A. De Beukelaar, and F. Krug, The immunological evaluation of levamisole treatment in cancer patients. Postgrad. Med. J. 54: 799 (1978).

    Article  Google Scholar 

  14. S. Pavlovsky, M.F. Sackman, G. Garay, E. Svarch, J. Braier, M. Lagarde, C. Scaglione, M. Eppinger-Helft, R. Failace, and E. Dibar, Chemoimmunotherapy with levamisole in acute lymphoblastic leukemia. Cancer 48: 1500 (1981).

    Article  PubMed  CAS  Google Scholar 

  15. B. Ramot, E. Rosenthal, M. Biniaminov, and I. Ben-Bassat, Effect of levamisole, thymic humoral factor and indomethacin on E-rosette-formation of lymphocytes in Hodgkin’s disease. Israel J. Med. Sci. 17: 232 (1981).

    PubMed  CAS  Google Scholar 

  16. G.S. Del Giacco, S. Tognella, A.L. Leone, F. Locci, P. Cornaglia, A. Sangiuolo, and V. Grifoni, Interference of levamisole with inhibition of E-rosette formation by Hodgkin’s disease and systemic lupus erythematosus cytotoxic sera. Blood 53: 1002 (1979).

    PubMed  Google Scholar 

  17. W. Amery, and D.A. Gough, Levamisole and immunotherapy: Some theoretical and practical considerations and their relevance to human disease. Oncology 38: 168 (1981).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Internal Medicine, Chair of Clinical Immunology, University of Cagliari Medical School, Cagliari, Italy

    G. S. Del Giacco, F. Locci, L. Cengiarotti, E. Chessa, A. Di Tucci, G. Meloni, E. Montaldo, M. Pautasso, G. Piludu & M. C. Piras

Authors
  1. G. S. Del Giacco
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Locci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Cengiarotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Chessa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Di Tucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Meloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Montaldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Pautasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Piludu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. C. Piras
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical University of South Carolina, Charleston, South Carolina, USA

    H. Hugh Fudenberg  & H. D. Whitten  & 

  2. University of Pisa, Pisa, Italy

    Fabio Ambrogi

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Plenum Press, New York

About this chapter

Cite this chapter

Del Giacco, G.S. et al. (1984). The Present Status of Clinical Use of Levamisole. In: Fudenberg, H.H., Whitten, H.D., Ambrogi, F. (eds) Immunomodulation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9358-4_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9358-4_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9360-7

  • Online ISBN: 978-1-4615-9358-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation